黄 静,杨青岩

尿白蛋白（urine albumin）是指通过肾小球的数量和肾小管重吸收能力之间的相互作用后在尿液中出现的白蛋白的数量，已出版的专业实践指南推荐使用定量测量尿白蛋白-肌酐的比值（ACR）来评估蛋白尿，近年来,许多国内外的研究发现蛋白尿与冠心病的患病率、冠状动脉病变的严重程度及心血管疾病风险分层都有密切的联系。在相关的心肾疾病研究中，有许多研究学者发现尿白蛋白可作为冠心病的预后及危险分层的独立预测因子。通过了解肾功能减退和心血管疾病相关作用的机制,对今后的医疗工作以及临床治疗方案的选择提供重要的指导意义依据。本研究就尿白蛋白和冠心病之间的关系做一综述。

冠心病；尿白蛋白；综述

[1] Tojo A, Kinugasa S. Mechanisms of glomerular albumin filtration and tubular reabsorption[J]. International Journal of Nephrology, 2012, 2012: 481520. [2] Lazzara M J, Deen W M. Model of albumin reabsorption in the proximal tubule[J]. American Journal of Physiology. Renal Physiology, 2007, 292(1): F430-439. [3] Mann S J, Gerber L M. Addressing the problem of inaccuracy of measured 24-hour urine collections due to incomplete collection[J]. Journal of Clinical Hypertension (Greenwich, Conn.), 2019, 21(11): 1626–1634. [4] Witte E C, Lambers Heerspink H J, de Zeeuw D, et al. First morning voids are more reliable than spot urine samples to assess microalbuminuria[J]. Journal of the American Society of Nephrology: JASN, 2009, 20(2): 436–443. [5] Lambers Heerspink H J, Gansevoort R T, Brenner B M, et al. Comparison of different measures of urinary protein excretion for prediction of renal events[J]. Journal of the American Society of Nephrology: JASN, 2010, 21(8): 1355–1360. [6] Al R A, Baykal C, Karacay O, et al. Random urine protein-creatinine ratio to predict proteinuria in new-onset mild hypertension in late pregnancy[J]. Obstetrics and Gynecology, 2004, 104(2): 367–371. [7] Levey A S, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification[J]. Annals of Internal Medicine, 2003, 139(2): 137–147. [8] Shimbo Y, Suzuki S, Ishii H, et al. Association of Estimated Glomerular Filtration Rate and Proteinuria With Lipid-Rich Plaque in Coronary Artery Disease[J]. Circulation Journal, 2015, 79(10): 2263–2270. [9] Hemmelgarn B R, Manns B J, Lloyd A, et al. Relation between kidney function, proteinuria, and adverse outcomes[J]. JAMA, 2010, 303(5): 423–429. [10] Tangri N, Stevens L A, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure[J]. JAMA, 2011, 305(15): 1553–1559. [11] Stevens P E, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline[J]. Annals of Internal Medicine, 2013, 158(11): 825–830. [12] Levey A S, de Jong P E, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report[J]. Kidney International, 2011, 80(1): 17–28. [13] Mann J F E, Yi Q-L, Gerstein H C. Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease[J]. Kidney International. Supplement, 2004(92): S59-62. [14] Silva R P, Cisne K, Oliveira J M de, et al. Determination of microalbuminuria in hypertensive patients and in patients with coronary artery disease[J]. Arquivos Brasileiros De Cardiologia, 2008, 90(2): 99–103. [15] Böhm M, Thoenes M, Danchin N, et al. Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: the i-SEARCH global study[J]. Journal of Hypertension, 2007, 25(11): 2317–2324. [16] Lunetta M, Infantone L, Calogero A E, et al. Increased urinary albumin excretion is a marker of risk for retinopathy and coronary heart disease in patients with type 2 diabetes mellitus[J]. Diabetes Research and Clinical Practice, 1998, 40(1): 45–51. [17] Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy - PubMed[EB/OL]. /2024-03-21. https://pubmed.ncbi.nlm.nih.gov/15302780/. [18] DeFilippis A P, Kramer H J, Katz R, et al. Association between coronary artery calcification progression and microalbuminuria: the MESA study[J]. JACC. Cardiovascular imaging, 2010, 3(6): 595–604. [19] Jadhav U M, Kadam N N. Association of microalbuminuria with carotid intima-media thickness and coronary artery disease--a cross-sectional study in Western India[J]. The Journal of the Association of Physicians of India, 2002, 50: 1124–1129. [20] Ibsen H, Olsen M H, Wachtell K, et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study[J]. Hypertension (Dallas, Tex.: 1979), 2005, 45(2): 198–202. [21] Zand Parsa A F, Ghadirian L, Rajabzadeh Kanafi S, et al. Positive correlation between microalbuminuria and severity of coronary artery stenosis in patients with type 2 diabetes mellitus[J]. Acta Medica Iranica, 2013, 51(4): 231–235. [22] Reza A S, Zaher A, Reza A Q M, et al. Correlation between microalbuminuria and angiographic severity of coronary artery disease[J]. Bangladesh Medical Research Council Bulletin, 2006, 32(3): 78–86. [23] Hoseini V N, Rasouli M. Microalbuminuria correlates with the prevalence and severity of coronary artery disease in non-diabetic patients[J]. Cardiology Journal, 2009, 16(2): 142–145. [24] Park H E, Heo N J, Kim M, et al. Significance of microalbuminuria in relation to subclinical coronary atherosclerosis in asymptomatic nonhypertensive, nondiabetic subjects[J]. Journal of Korean Medical Science, 2013, 28(3): 409–414. [25] Guo L-X, Ma J, Cheng Y, et al. Urinary albumin excretion rate is correlated with severity of coronary artery disease in elderly type 2 diabetic patients[J]. Chinese Medical Journal, 2012, 125(23): 4181–4184. [26] Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes - PubMed[EB/OL]. /2024-02-21. https://pubmed.ncbi.nlm.nih.gov/6690964/. [27] Urinary albumin and insulin as predictors of coronary artery disease: An angiographic study - PubMed[EB/OL]. /2024-02-19. https://pubmed.ncbi.nlm.nih.gov/10561150/. [28] Kim J-J, Hwang B-H, Choi I J, et al. A prospective two-center study on the associations between microalbuminuria, coronary atherosclerosis and long-term clinical outcome in asymptomatic patients with type 2 diabetes mellitus: evaluation by coronary CT angiography[J]. The International Journal of Cardiovascular Imaging, 2015, 31(1): 193–203. [29] Ganbaatar N, Kadota A, Hisamatsu T, et al. Relationship between Kidney Function and Subclinical Atherosclerosis Progression Evaluated by Coronary Artery Calcification[J]. Journal of Atherosclerosis and Thrombosis, 2022, 29(9): 1359–1371. [30] Gerstein H C, Mann J F, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals[J]. JAMA, 2001, 286(4): 421–426. [31] Volpe M, Cosentino F, Ruilope L M. Is it time to measure microalbuminuria in hypertension?[J]. Journal of Hypertension, 2003, 21(7): 1213–1220. [32] Cao J J, Biggs M L, Barzilay J, et al. Cardiovascular and mortality risk prediction and stratification using urinary albumin excretion in older adults ages 68-102: the Cardiovascular Health Study[J]. Atherosclerosis, 2008, 197(2): 806–813. [33] Mattock M B, Barnes D J, Viberti G, et al. Microalbuminuria and coronary heart disease in NIDDM: an incidence study[J]. Diabetes, 1998, 47(11): 1786–1792. [34] Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes[J]. Circulation, 2004, 110(1): 32–35. [35] X L, W S, Y Z, et al. Elevated urine albumin creatinine ratio increases cardiovascular mortality in coronary artery disease patients with or without type 2 diabetes mellitus: a multicenter retrospective study[J]. Cardiovascular diabetology, Cardiovasc Diabetol, 2023, 22(1). [36] Stehouwer C D A, Smulders Y M. Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms[J]. Journal of the American Society of Nephrology: JASN, 2006, 17(8): 2106–2111. [37] Schiffrin E L, Lipman M L, Mann J F E. Chronic Kidney Disease: Effects on the Cardiovascular System[J]. Circulation, 2007, 116(1): 85–97. [38] Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study - PubMed[EB/OL]. /2024-02-21. https://pubmed.ncbi.nlm.nih.gov/11012904/. [39] Campean V, Neureiter D, Varga I, et al. Atherosclerosis and vascular calcification in chronic renal failure[J]. Kidney & Blood Pressure Research, 2005, 28(5–6): 280–289. [40] Gui M, Hong J, Lü A, et al. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status[J]. Chinese Medical Journal, 2008, 121(24): 2509–2516. [41] Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus - PubMed[EB/OL]. /2024-02-21. https://pubmed.ncbi.nlm.nih.gov/1353802/. [42] Endemann D H, Schiffrin E L. Endothelial dysfunction[J]. Journal of the American Society of Nephrology: JASN, 2004, 15(8): 1983–1992. [43] Bundy J D, Chen J, Yang W, et al. Risk factors for progression of coronary artery calcification in patients with chronic kidney disease: The CRIC study[J]. Atherosclerosis, 2018, 271: 53–60. [44] Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality - PubMed[EB/OL]. /2024-03-24. https://pubmed.ncbi.nlm.nih.gov/12937218/. [45] Nakamura S, Ishibashi-Ueda H, Niizuma S, et al. Coronary calcification in patients with chronic kidney disease and coronary artery disease[J]. Clinical journal of the American Society of Nephrology: CJASN, 2009, 4(12): 1892–1900. [46] Nakano T, Ninomiya T, Sumiyoshi S, et al. Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama study[J]. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation, 2010, 55(1): 21–30. [47] Sandhu S, Wiebe N, Fried L F, et al. Statins for improving renal outcomes: a meta-analysis[J]. Journal of the American Society of Nephrology: JASN, 2006, 17(7): 2006–2016.

点击下载PDF